A guestimate.. Nov revenue Ann on 22nd or 23rd with equally if not slightly better results than Oct.. Setting it up nicely for 2019.. we will see..
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025